Embecta Corp.
Embecta Corp. (EMBC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EMBC · as of Jun 8, 2026
Key Statistics
Explore Embecta Corp. Data
embc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 0.0%
The EMBC analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +49.70% upside from the current price of $3.34.
Competitors & Peers
embc competitorsEMBC
AQST
CDNA
EBS
EVH
MRVIStock Performance
Full HistoryAbout Embecta Corp.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essenti…
what is embecta corp. · embc stock overview · embecta corp. company profile · who is embecta corp. ceo · embc NASDAQ · embecta corp. headquarters · embecta corp. business segments
About Stock Overview & Key Data
Embecta Corp. (EMBC) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 22, 2022. As of the latest trading session, EMBC stock price is $3.34, with a market capitalization of $198.2M. The stock has returned -65.89% over the past 12 months and -71.55% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Embecta Corp. stock is Hold, with an average 12-month price target of $5.00. In fiscal year 2025, Embecta Corp. reported revenue of $1.1B and net income of $95.4M. For detailed data — including Embecta Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Embecta Corp. (EMBC) stock price is $3.34. The stock is traded on NASDAQ under the ticker symbol EMBC. The 52-week range is $2.77 – $15.55.